Welcome back,

CONFERENCE UPDATE

ASH 2025

2025 American Society of Hematology Annual Meeting

December 6-9 , 2025 |

Orlando, United States

2025

Early initiation of luspatercept derives greater benefit in ESA-naive TD LR-MDS: Post-hoc analysis of the phase 3 COMMANDS trial
HEMATOLOGY

10 Apr 2026
Efanesoctocog alfa offers sustained prophylaxis in severe hemophilia A: Interim analysis of the XTEND-ed LTE study
HEMATOLOGY

28 Feb 2026
Ponatinib + blinatumomab vs. imatinib + chemotherapy in newly diagnosed adult Ph+ ALL: First results from the GIMEMA ALL2820
HEMATOLOGY

15 Feb 2026
Post-HSCT gilteritinib resumption improves OS in R/R FLT3mut+ AML: Pooled analysis of the phase 3 ADMIRAL and COMMODORE trials
HEMATOLOGY

29 Jan 2026
IV iron use during acute infections associated with lower mortality in IDA
HEMATOLOGY

28 Jan 2026
Improved survival outcomes observed with non-TBI-based conditioning in NGS-MRD-negative B-ALL undergoing allogeneic HCT
HEMATOLOGY

28 Jan 2026

eaa0190a-4510-467f-900f-c94c7b668484